Boston Biotech Conferences Announces the Appointment of Xconomy Founder Bob Buderi as Chairman
Buderi brings decades of experience with biotech and biopharma that will help connect attendees to an extensive network of industry experts.
BOSTON, Sept. 5, 2018 /PRNewswire-PRWeb/ -- Boston Biotech Conferences, producer of exclusive C-suite meetings for the biotech community, announces the appointment of Bob Buderi as its new Chairman.
As Founder and Editor-in-Chief of Xconomy and a past Editor of MIT's Technology Review magazine, Buderi brings decades of experience with biotech and biopharma that will help connect attendees to an extensive network of industry experts. He will lead the charge in helping the business better position its offering to shape the future of biotech.
"I'm really excited to be working with this series of exclusive peer-to-peer CEO meetings. We will be striving to bring the most relevant topics to the forefront—giving biotech leaders the opportunity to share insights and contribute to meaningful conversations with their peers." - Bob Buderi, Chairman of Boston Biotech Conferences.
The format of these meetings will be heavily influenced by the community, for the community. Under Buderi's chairmanship, a select group of Ambassadors will advise on overall strategy, contribute insights, and help pinpoint important trends. The committee will include industry leaders Mike Gilman Ph.D., Chairman and CEO of Arrakis Therapeutics; Rachel Haurwitz Ph.D., President and CEO of Caribou Biosciences; and Jeremy M. Levin D.Phil. MB BChir, Chairman and CEO of Ovid Therapeutics. Further information about the committee, including a formal introduction to all the Ambassadors, will be shared in October.
More exciting changes are on the horizon for Boston Biotech Conferences. Look for those announcements in the coming months.
About Boston Biotech Conferences:
Boston Biotech Conferences are exclusive, thought-leader forums for senior biopharma executives. Each conference is highly interactive and co-hosted by healthcare industry leaders to foster discussions and facilitate information-sharing, networking and corporate development within the biopharma community. These meetings convene the most relevant players in biotech to network, collaborate and leverage the experiences of their peers in an off-the-record setting. For more information, please visit: http://www.bostonbiotechconferences.com.
Contact:
Boston Biotech Conferences
Suzanne Carroll
suzanne (at) bbbiotechconference (dot) com
+1 857-504-6715
SOURCE Boston Biotech Conferences
Share this article